Original Article
Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus
Consenso multidisciplinario sobre el uso de hidroxicloroquina en los pacientes con lupus eritematoso sistémico
Íñigo Rúa-Figueroaa, Tarek Carlos Salman-Monteb, José María Pego Reigosac, María Galindo Izquierdod, Elvira Díez Álvareze, Antonio Fernández-Nebrof, José Andrés Román Ivorrag, Inmaculada Calvo Penadesh, Joseba Artaraz Beobidei, Jaime Calvo Alénj,k,l,
a Rheumatology Department, Gran Canaria University Hospital Doctor Negrin, Las Palmas de Gran Canaria, Spain
b Rheumatology Department, Hospital del Mar-Parc de Salut MAR, Barcelona, Spain
c Rheumatology Department, University Hospital of Vigo, IRIDIS-VIGO Group (Investigation in Rheumatology and Immune-Mediated Diseases), Galicia South Health Research Institute (IISGS), Vigo, Spain
d Rheumatology Department, 12 de Octubre University Hospital, Madrid, Spain
e Rheumatology Department, León University Health Care Complex, León, Spain
f Biomedical Research Institute of Malaga (IBIMA) – Plataforma Bionand, UGC of Rheumatology, Regional University Hospital of Malaga, Department of Medicine and Dermatology, University of Malaga, Malaga, Spain
g Department of Rheumatology, La Fe University and Polytechnic Hospital, Valencia, Spain
h Pediatric Rheumatology Unit, La Fe University and Polytechnic Hospital, Valencia, Spain
i Department of Ophthalmology, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, Barakaldo, Spain
j Rheumatology Department, Araba University Hospital, Vitoria, Spain
k Research Institute BIOARABA, Spain
l País Vasco University, Spain
Ver másRead
1578
Timeswas read the article
522
Total PDF
1056
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 7 | 18 | 25 |
| 2025 5 | 349 | 125 | 474 |
| 2025 4 | 260 | 73 | 333 |
| 2025 3 | 127 | 75 | 202 |
| 2025 2 | 105 | 85 | 190 |
| 2025 1 | 96 | 62 | 158 |
| 2024 12 | 102 | 77 | 179 |
| 2024 11 | 2 | 4 | 6 |
| 2024 10 | 5 | 2 | 7 |
| 2024 9 | 2 | 0 | 2 |
| 2024 8 | 1 | 1 | 2 |
